Toward intensifying design of experiments in upstream bioprocess development: An industrial Escherichia coli feasibility study

In this study, step variations in temperature, pH, and carbon substrate feeding rate were performed within five high cell density Escherichia coli fermentations to assess whether intraexperiment step changes, can principally be used to exploit the process operation space in a design of experiment manner. A dynamic process modeling approach was adopted to determine parameter interactions. A bioreactor model was integrated with an artificial neural network that describes biomass and product formation rates as function of varied fed‐batch fermentation conditions for heterologous protein production. A model reliability measure was introduced to assess in which process region the model can be expected to predict process states accurately. It was found that the model could accurately predict process states of multiple fermentations performed at fixed conditions within the determined validity domain. The results suggest that intraexperimental variations of process conditions could be used to reduce the number of experiments by a factor, which in limit would be equivalent to the number of intraexperimental variations per experiment. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:1343–1352, 2016

[1]  Rui Oliveira,et al.  Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study , 2016, Bioprocess and Biosystems Engineering.

[2]  S. Feyo de Azevedo,et al.  Bioprocess hybrid parametric/nonparametric modelling based on the concept of mixture of experts , 2008 .

[3]  Carl-Fredrik Mandenius,et al.  Bioprocess optimization using design‐of‐experiments methodology , 2008, Biotechnology progress.

[4]  Bas Diepenbroek,et al.  Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations. , 2014, Trends in biotechnology.

[6]  Mike Tobyn,et al.  Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era , 2015, Pharmaceutical development and technology.

[7]  B. Glick Metabolic load and heterologous gene expression. , 1995, Biotechnology advances.

[8]  Wolfgang Marquardt,et al.  The validity domain of hybrid models and its application in process optimization , 2007 .

[9]  René H. Wijffels,et al.  Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production , 2013 .

[10]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[11]  Rui Oliveira,et al.  Bioprocess Iterative Batch‐to‐Batch Optimization Based on Hybrid Parametric/Nonparametric Models , 2006, Biotechnology progress.

[12]  R. Simutis,et al.  Avoiding overfeeding in high cell density fed-batch cultures of E. coli during the production of heterologous proteins. , 2014, Journal of biotechnology.

[13]  S. Jørgensen,et al.  A biochemically structured model for Saccharomyces cerevisiae. , 2001, Journal of biotechnology.

[14]  J. Heijnen,et al.  Understanding and applying the extrapolation properties of serial gray-box models , 1998 .

[15]  Lyle H. Ungar,et al.  A hybrid neural network‐first principles approach to process modeling , 1992 .

[16]  Rui Oliveira Combining first principles modelling and artificial neural networks: a general framework , 2004, Comput. Chem. Eng..

[17]  Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development , Manufacturing , and Quality Assurance , 2004 .

[18]  R. Simutis,et al.  Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes , 2010, Applied Microbiology and Biotechnology.

[19]  Mitchell Tai,et al.  Efficient high‐throughput biological process characterization: Definitive screening design with the Ambr250 bioreactor system , 2015, Biotechnology progress.

[20]  Oliver Spadiut,et al.  A dynamic method based on the specific substrate uptake rate to set up a feeding strategy for Pichia pastoris , 2011, Microbial cell factories.

[21]  P. Hagander,et al.  Avoiding acetate accumulation in Escherichia coli cultures using feedback control of glucose feeding. , 2001, Biotechnology and bioengineering.

[22]  R. Simutis,et al.  Product formation kinetics in genetically modified E. coli bacteria: inclusion body formation , 2008, Bioprocess and biosystems engineering.

[23]  Sebastião Feyo de Azevedo,et al.  Hybrid semi-parametric modeling in process systems engineering: Past, present and future , 2014, Comput. Chem. Eng..

[24]  Wee Chew,et al.  Trends in process analytical technology , 2010 .

[25]  Carl-Fredrik Mandenius,et al.  Process analytical technology (PAT) for biopharmaceuticals , 2011, Biotechnology journal.

[26]  Rui Oliveira,et al.  Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry. , 2014, Biotechnology journal.

[27]  Margaret J. Robertson,et al.  Design and Analysis of Experiments , 2006, Handbook of statistics.

[28]  K. Shimizu Metabolic Regulation of a Bacterial Cell System with Emphasis on Escherichia coli Metabolism , 2013, ISRN biochemistry.